The table below shows Protagonist Therapeutics, Inc's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$56.37M
$4.71M
$5.55M
$28.32M
$4.67M
$4.17M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$46.74M
$40.00M
$37.04M
$35.89M
$35.97M
$33.52M
SG&A
PTGX annual revenue (10-K history)
Protagonist Therapeutics, Inc reported annual revenue of $46.02M for fiscal year 2025. That is down 89.4% from $434.43M in fiscal 2024. Over the 9 fiscal years shown, annual revenue grew from $20.06M (FY 2017) to $46.02M. Figures come from the company's audited annual reports as filed with the SEC.